The primary purpose of this study is to evaluate the safety and efficacy of postoperative
intravenous ferric carboxymaltose in patients with anemia undergoing Simultaneous Bilateral
Total knee replacement in terms of Quality of life (QOL) and objective measures (Hemoglobin
and Iron parameters).